Tonix Pharmaceuticals has partnered with Bilthoven Biologicals to advance its mpox vaccine candidate, TNX-801. This collaboration aims to develop a safe and effective vaccine to combat the growing threat of mpox, especially in light of the recent WHO public health emergency declaration.